Board Meeting6 May 2026, 05:01 pm
Venmax Drugs Board Meeting on May 14, 2026 to Approve Audited Results
AI Summary
Venmax Drugs and Pharmaceuticals Ltd has scheduled a Board of Directors meeting on May 14, 2026, to consider and approve the Audited Standalone Financial Results for the quarter and year ended March 31, 2026. The trading window, which has been closed since April 1, 2026, will remain closed until May 16, 2026, 48 hours after the approval of the results.
Key Highlights
- Venmax Drugs board meeting set for May 14, 2026.
- Meeting to approve audited financial results for the quarter and year ended March 31, 2026.
- Trading window remains closed until May 16, 2026.
- Closure is 48 hours post-approval of audited standalone financial results.
Price Impact
More from VENMAX
More in Board Meeting